Jasper Therapeutics, Inc. (JSPR)
0.6932
-0.02
(-2.28%)
USD |
NASDAQ |
Sep 09, 14:40
Jasper Therapeutics Market Cap : 19.46M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 19.92M |
| September 04, 2026 | 19.90M |
| September 03, 2026 | 19.27M |
| September 02, 2026 | 19.79M |
| September 01, 2026 | 19.59M |
| August 31, 2026 | 19.98M |
| August 28, 2026 | 19.65M |
| August 27, 2026 | 19.63M |
| August 26, 2026 | 20.16M |
| August 25, 2026 | 20.22M |
| August 24, 2026 | 20.28M |
| August 21, 2026 | 20.10M |
| August 20, 2026 | 19.41M |
| August 19, 2026 | 20.96M |
| August 18, 2026 | 21.06M |
| August 17, 2026 | 23.65M |
| August 14, 2026 | 22.19M |
| August 13, 2026 | 24.24M |
| August 12, 2026 | 23.13M |
| August 11, 2026 | 25.08M |
| August 10, 2026 | 22.38M |
| August 07, 2026 | 19.86M |
| August 06, 2026 | 18.09M |
| August 05, 2026 | 18.48M |
| August 04, 2026 | 18.63M |
| Date | Value |
|---|---|
| August 03, 2026 | 16.97M |
| July 31, 2026 | 17.64M |
| July 30, 2026 | 17.38M |
| July 29, 2026 | 16.80M |
| July 28, 2026 | 17.72M |
| July 27, 2026 | 19.44M |
| July 24, 2026 | 19.27M |
| July 23, 2026 | 20.41M |
| July 22, 2026 | 20.85M |
| July 21, 2026 | 21.56M |
| July 20, 2026 | 22.79M |
| July 17, 2026 | 24.78M |
| July 16, 2026 | 21.67M |
| July 15, 2026 | 19.37M |
| July 14, 2026 | 20.24M |
| July 13, 2026 | 17.02M |
| July 10, 2026 | 16.22M |
| July 09, 2026 | 16.28M |
| July 08, 2026 | 14.41M |
| July 07, 2026 | 13.49M |
| July 06, 2026 | 13.05M |
| July 02, 2026 | 11.99M |
| July 01, 2026 | 12.72M |
| June 30, 2026 | 11.79M |
| June 29, 2026 | 11.75M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 296.18M |
| Amgen, Inc. | 211.80B |
| Anika Therapeutics, Inc. | 281.44M |
| BioCryst Pharmaceuticals, Inc. | 2.340B |
| Imunon, Inc. | 7.185M |
Market Cap Related Metrics
| Price to Book Value | 13.78 |
| Price | 0.6932 |
| Earnings Yield | -228.1% |